Literature DB >> 35468998

Targeted therapies for cardiac diseases.

Christoph Maack1,2, Jil C Tardiff3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35468998     DOI： 10.1038/s41569-022-00704-x

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   49.421


× No keyword cloud information.
  5 in total

Review 1.  A cardioimmunologist's toolkit: genetic tools to dissect immune cells in cardiac disease.

Authors:  Anthony Wong; Homaira Hamidzada; Slava Epelman
Journal:  Nat Rev Cardiol       Date:  2022-05-06       Impact factor: 32.419

Review 2.  Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancer.

Authors:  Anja Karlstaedt; Javid Moslehi; Rudolf A de Boer
Journal:  Nat Rev Cardiol       Date:  2022-04-19       Impact factor: 32.419

Review 3.  Neuroimmune axis of cardiovascular control: mechanisms and therapeutic implications.

Authors:  Daniela Carnevale
Journal:  Nat Rev Cardiol       Date:  2022-03-17       Impact factor: 32.419

Review 4.  Targeting the sarcomere in inherited cardiomyopathies.

Authors:  Sarah J Lehman; Claudia Crocini; Leslie A Leinwand
Journal:  Nat Rev Cardiol       Date:  2022-03-18       Impact factor: 49.421

Review 5.  The microtubule cytoskeleton in cardiac mechanics and heart failure.

Authors:  Matthew A Caporizzo; Benjamin L Prosser
Journal:  Nat Rev Cardiol       Date:  2022-04-19       Impact factor: 49.421
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.